EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.
The guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The aims of the guidelines are to assist nuclear medicine practitioners in making recommendations, performing, interpreting and reporting the results of clinical dopamine D2 receptor SPECT or PET studies, and to achieve a high quality standard of dopamine D2 receptor imaging, which will increase the impact of this technique in neurological practice.The present document is an update of the first guidelines for SPECT using D2 receptor ligands labelled with (123)I [1] and was guided by the views of the Society of Nuclear Medicine Brain Imaging Council [2], and the individual experience of experts in European countries. The guidelines intend to present information specifically adapted to European practice. The information provided should be taken in the context of local conditions and regulations.
Van Laere
Koen
K
Division of Nuclear Medicine, University Hospital Leuven, Herestraat 49, 3000, Leuven, Belgium. koen.vanlaere@uzleuven.be
Varrone
Andrea
A
Booij
Jan
J
Vander Borght
Thierry
T
Nobili
Flavio
F
Kapucu
Ozlem L
OL
Walker
Zuzana
Z
Någren
Kjell
K
Tatsch
Klaus
K
Darcourt
Jacques
J
D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism*; D004298:Dopamine / Q000493:pharmacokinetics*; D005062:European Union; D005260:Female; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography / Q000592:standards*; D017410:Practice Guidelines as Topic; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D009435:Synaptic Transmission / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon / Q000592:standards*
D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2; D004298:Dopamine